Your browser doesn't support javascript.
loading
Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.
Wang, Jia; Zuo, Jie; Wahafu, Alafate; Wang, Mao-de; Li, Rui-Chun; Xie, Wan-Fu.
Afiliación
  • Wang J; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Zuo J; Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wahafu A; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wang MD; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Li RC; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Xie WF; Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
CNS Neurosci Ther ; 26(3): 297-308, 2020 03.
Article en En | MEDLINE | ID: mdl-31318172
INTRODUCTION: Glioblastoma (GBM) is the most lethal primary malignant brain tumor in adults with poor survival due to acquired therapeutic resistance and rapid recurrence. Currently, the standard clinical strategy for glioma includes maximum surgical resection, radiotherapy, and temozolomide (TMZ) chemotherapy; however, the median survival of patients with GBM remains poor despite these comprehensive therapies. Therefore, the identification of new prognostic biomarkers is urgently needed to evaluate the malignancy and long-term outcome of glioma. AIMS: To further investigate prognostic biomarkers and potential therapeutic targets for GBM. RESULTS: In this study, we identified tribbles pseudokinase 2 (TRIB2) as one of the genes that is most correlated with pathological classification, radioresistance, and TMZ resistance in glioma. Additionally, the expression of mitogen-activated protein kinase kinase kinase 1 (MAP3K1) showed a strong correlation with TRIB2. Moreover, a combined increase in TRIB2 and MAP3K1 was observed in GBM and indicated a poor prognosis of patients with glioma. Finally, enriched TRIB2 expression and MAP3K1 expression were shown to be associated with resistance to TMZ and radiotherapy. CONCLUSION: Combined elevation of TRIB2 and MAP3K1 could be novel prognostic biomarkers and potential therapeutic targets to evaluate the malignancy and long-term outcomes of GBM.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Proteínas Quinasas Dependientes de Calcio-Calmodulina / Glioblastoma / Resistencia a Antineoplásicos / Quinasa 1 de Quinasa de Quinasa MAP / Temozolomida Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: CNS Neurosci Ther Asunto de la revista: NEUROLOGIA / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Proteínas Quinasas Dependientes de Calcio-Calmodulina / Glioblastoma / Resistencia a Antineoplásicos / Quinasa 1 de Quinasa de Quinasa MAP / Temozolomida Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: CNS Neurosci Ther Asunto de la revista: NEUROLOGIA / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido